Gaze and Gait Training With rTMS

Sponsor
University of Florida (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05864313
Collaborator
(none)
30
2
24

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the feasibility of combining repetitive transcranial magnetic stimulation (rTMS), gaze and gait training to improve walking and balance in people with or without mild cognitive impairment.

Condition or Disease Intervention/Treatment Phase
  • Device: Repetitive Transcranial Magnetic Stimulation (rTMS)
  • Behavioral: Gait training
  • Behavioral: Gaze training
  • Device: Sham rTMS
N/A

Detailed Description

The study plan is to recruit a total of 15 cognitively impaired and 15 healthy adults. The study will involve two visits. Each study visit will involve:

  • Real rTMS or sham rTMS that last about 60 minutes

  • Gaze stabilization exercise via a virtual reality headset for about 1-hour

  • Target stepping on a treadmill for about 1-hour

Researchers will compare changes in gaze and gait following training sessions with real rTMS and sham rTMS.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Basic Science
Official Title:
Gaze and Gait Training With Neuromodulation
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2025
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Real 10 Hz rTMS

Participants will receive 1 hour of real rTMS followed by 1 hour of gaze and gait training.

Device: Repetitive Transcranial Magnetic Stimulation (rTMS)
10 Hz rTMS for 5 seconds over the frontal eye fields with 25 second intertrain interval for 10 trains (500 pulses) at 90% of the resting motor threshold,
Other Names:
  • 10 Hz rTMS FEF
  • Behavioral: Gait training
    Subjects will practice stepping on virtual targets with real-time feedback of their foot position displayed on a screen while walking on a treadmill.

    Behavioral: Gaze training
    Subjects will perform gaze stabilization and gaze shifting exercise via a virtual reality headset.

    Sham Comparator: sham rTMS

    Participants will receive 1 hour of sham rTMS followed by 1 hour of gaze and gait training.

    Behavioral: Gait training
    Subjects will practice stepping on virtual targets with real-time feedback of their foot position displayed on a screen while walking on a treadmill.

    Behavioral: Gaze training
    Subjects will perform gaze stabilization and gaze shifting exercise via a virtual reality headset.

    Device: Sham rTMS
    Sham rTMS stimulation will produce discharge noise and vibration without stimulating the cerebral cortex.

    Outcome Measures

    Primary Outcome Measures

    1. Change in Foot Placement Error from baseline 1 [Beginning and end of Visit 1, an average of 8 hours]

      Foot position relative to stepping targets.

    2. Change in VOR Gain from baseline 1 [Beginning and end of Visit 1, an average of 8 hours]

      The amount of eye relative to head movement during active head rotations.

    3. Change in Foot Placement Error from baseline 2 [Beginning and end of Visit 2, an average of 8 hours]

      Foot position relative to stepping targets.

    4. Change in VOR Gain from baseline 2 [Beginning and end of Visit 2, an average of 8 hours]

      The amount of eye relative to head movement during active head rotations.

    Secondary Outcome Measures

    1. Change in Timed Up and Go (TUG) from baseline 1 [Beginning and end of Visit 1, an average of 8 hours]

      The TUG assesses mobility, balance, waking ability and fall risk in older adults. A higher risk for falling is indicated by >= 12 seconds to complete the test.

    2. Change in Timed Up and Go (TUG) from baseline 2 [Beginning and end of Visit 2, an average of 8 hours]

      The TUG assesses mobility, balance, waking ability and fall risk in older adults. A higher risk for falling is indicated by >= 12 seconds to complete the test.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age 18 - 80 years

    • Capable of providing informed consent and complying to the experimental procedures

    Exclusion Criteria:
    • Significant gait difficulty requiring ambulatory aids

    • Presence of implanted device such as a neurostimulator, cochlear implant or pacemaker

    • History of epilepsy

    • History of hearing issues

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University of Florida

    Investigators

    • Principal Investigator: Julia Choi, Ph.D., University of Florida

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Florida
    ClinicalTrials.gov Identifier:
    NCT05864313
    Other Study ID Numbers:
    • IRB202300184
    First Posted:
    May 18, 2023
    Last Update Posted:
    May 18, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 18, 2023